Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse

Multiple Sclerosis and Related Disorders

Volumn 1, Issue 1, 2012, Pages 29-38

  Al Izki, Sarah ^a   Pryce, Gareth ^a   O'Neill, Janet K ^b   Butter, Colin ^b,d   Giovannoni, Gavin ^a   Amor, Sandra ^a,c   Baker, David ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Royal College of England   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Autoimmunity; Encephalomyelitis; Experimental autoimmune; Immune tolerance; Multiple sclerosis model; Neurodegeneration; Outcome measures

Indexed keywords

EID: 80054714639     PISSN: 22110348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msard.2011.09.001     Document Type: Article

References (52)

1. Aicher SA, Silverman MB, Winkler CW, Bebo Jr. BF. Hyperalgesia in an animal model of multiple sclerosis. Pain 2004;110:560-70. (Pubitemid 39036787)
2. Al-Izki S, Pryce G, Giovannoni G, Baker D. Evaluating potential therapies for bladder dysfunction in a mouse model of multiple sclerosis with high- resolution ultrasonography. Multiple Sclerosis 2009;15:795-801.
3. Al-Izki S, Pryce G, Jackson SJ, Giovannoni G, Baker D. Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis. Multiple Sclerosis 2011.
4. Allen Sj, Baker D, O'Neill JK, Davison AN, Turk JL. Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Cellular Immunology 1993;146:335-50. (Pubitemid 23070308)
5. Amor S, Baker D, Groome N, Turk JL. Identification of a major encephalitogenic epitope of proteolipid protein (residues 56-70) for the induction of experimental allergic encephalomyelitis in Biozzi AB/H and nonobese diabetic mice. Journal of Immunology 1993;150:5666-72. (Pubitemid 23180680)
6. Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu JM, Baker D. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. Journal of Immunology 1994;153:4349-56. (Pubitemid 24346829)
7. Amor S, O'Neill Jk, Morris MM, Smith RM, Wraith DC, Groome N, Travers PJ, Baker D. Encephalitogenic epitopes of myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein for experimental allergic encephalomye- litis induction in Biozzi ABH (H-2Ag7) mice share an amino acid motif. Journal of Immunology 1996;156:3000-8. (Pubitemid 126660650)
8. Amor S, Smith PA, Hart B, Baker D. Biozzi mice: of mice and human neurological diseases. Journal of Neuroimmunology 2005;165:1-10. (Pubitemid 40984618)
9. Baker D, Amor S. Quality control of experimental autoimmune encephalomyelitis. Multiple Sclerosis. 2010;16:1025-7.
10. Critical appraisal of animal models of multiple sclerosis. Multiple Sclerosis.
11. Baker D, O'Neill JK, Davison AN, Turk JL. Control of immune-mediated disease of the central nervous system requires the use of a neuroactive agent: elucidation by the action of mitoxantrone. Clinical and Experimental Immunology 1992;90:124-8.
12. Baker D, O'Neill JK, Gschmeissner SE, Wilcox CE, Butter C, Turk JL. Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. Journal of Neuroimmunology 1990;28:261-70. (Pubitemid 20207821)
13. Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L. Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 2000;404:84-7. (Pubitemid 30143137)
14. Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Makriyannis A, Khanolkar A, Layward L, Fezza F, Bisogno T, Di Marzo V. Endocannabinoids control spasticity in a multiple sclerosis model. FASEB Journal 2001;15:300-2.
15. Black JA, Waxman SG. Phenytoin protects central axons in experimental autoimmune encephalomyelitis. Journal of Neurological Science 2008;274:57-63.
16. Brennan FR, O'Neill JK, Allen SJ, Butter C, Nuki G, Baker D. CD44 is involved in selective leucocyte extravasation during inflammatory central nervous system disease. Immunology 1999;98:427-35. (Pubitemid 29526967)
17. Brown A, McFarlin DE, Raine CS. Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Laboratory Investigation 1982;46:171-85. (Pubitemid 12181058)
18. Brown AM, McFarlin DE. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Laboratory Investigation 1981;45:278-84. (Pubitemid 11000173)
19. Buddeberg BS, Kerschensteiner M, Merkler D, Stadelmann C, Schwab ME. Behavioral testing strategies in a localized animal model of multiple sclerosis. Journal of Neuroimmunology 2004;153:158-70. (Pubitemid 38950938)
20. Butter C, Baker D, O'Neill JK, Turk JL. Mononuclear cell trafficking and plasma protein extravasation into the CNS during chronic relapsing experimental allergic encephalomyelitis in Biozzi AB/H mice. Journal of Neurological Science 1991;104:9-12.
21. Coles AJ, Wing M, Smith S, Coraddu F, Greer S, Taylor C, Weetman A, Hale G, Chatterjee VK, Waldmann H, Compston A. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 1999;354:1691-5. (Pubitemid 29533060)
22. Coles AJ, Wing MG, Molyneux P, Paolillo A, Davie CM, Hale G, Miller D, Waldmann H, Compston A. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Annals of Neurology 1999;46:296-304. (Pubitemid 29416266)
23. Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221-31. (Pubitemid 34304266)
24. Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502-17.
25. Fairchild PJ, Wildgoose R, Atherton E, Webb S, Wraith DC. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. International Immunology 1993;5:1151-8. (Pubitemid 23291164)
26. Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sorensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ. A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. New England Journal of Medicine 2010;362:416-26.
27. Hampton DW, Anderson J, Pryce G, Irvine KA, Giovannoni G, Fawcett JW, Compston A, Franklin RJ, Baker D, Chandran S. An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss. Journal of Neuroimmunology 2008;201-202:200-11.
28. Hankey DJ, Nickerson JM, Donoso LA, Lightman SL, Baker D. Experimental autoimmune uveoretinitis in mice (Biozzi ABH and NOD) expressing the autoimmune-associated H-2A(g7) molecule: identification of a uveitogenic epitope. Journal of Neuroimmunology 2001;118:212-22. (Pubitemid 32728355)
29. Heremans H, Dillen C, Groenen M, Martens E, Billiau A. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma. European Journal of Immunology 1996;26:2393-8. (Pubitemid 26340941)
30. Heremans H, Dillen C, Groenen M, Matthys P, Billiau A. Role of endogenous interleukin-12 (1L-12) in induced and spontaneous relapses of experimental autoimmune encephalomyelitis in mice. European Cytokine Network 1999; 10:171-80.
31. Inglese M, Mancardi GL, Pagani E, Rocca MA, Murialdo A, Saccardi R, Comi G, Filippi M. Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation. Journal of Neurology, Neurosurgery and Psychiatry 2004;75:643-4.
32. Jackson SJ, Lee J, Nikodemova M, Fabry Z, Duncan ID. Quantification of myelin and axon pathology during relapsing progressive experimental autoimmune ence- phalomyelitis in the Biozzi ABH mouse. Journal of Neuropathology and Experimental Neurology 2009;68:616-25.
33. Jackson SJ, Pryce G, Diemel LT, Cuzner ML, Baker D. Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation. Neuroscience 2005;134:261-8. (Pubitemid 40943652)
34. Jones MV, Nguyen TT, Deboy CA, Griffin JW, Whartenby KA, Kerr DA, Calabresi PA. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 2008;199:83-93.
35. Kerschensteiner M, Stadelmann C, Buddeberg BS, Merkler D, Bareyre FM, Anthony DC, Linington C, Bruck W, Schwab ME. Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. American Journal of Pathology 2004;164:1455-69. (Pubitemid 38387811)
36. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARR1VE guidelines for reporting animal research. PLoS Biology 2010;8:e1000412.
37. Kuerten S, Gruppe TL, Laurentius LM, Kirch C, Tary-Lehmann M, Lehmann PV, Addicks K. Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice. Acta Pathologica, Microbiologica et 1mmunologica Scandinavica 2011;119:336-46.
38. Levine S, Sowinski R. Experimental allergic encephalomyelitis in inbred and outbred mice. Journal of Immunology 1973;110:139-43.
39. Liu GY, Baker D, Fairchild S, Figueroa F, Quartey-Papafio R, Tone M, Healey D, Cooke A, Turk JL, Wraith DC. Complete characterization of the expressed immune response genes in Biozzi AB/H mice: structural and functional identity between Ab/h and NOD A region molecules. Immunogenetics 1993;37:296-300. (Pubitemid 23035120)
40. Miller SD, Karpus WJ, Davidson TS. Experimental autoimmune encephalomyelitis in the mouse. Current Protocols in Immunology 2010. [Chapter 15, Unit 15 11].
41. O'Neill JK, Baker D, Davison AN, Allen SJ, Butter C, Waldmann H, Turk JL. Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies. Journal of Neuroimmunology 1993;45:1-14. (Pubitemid 23224375)
42. O'Neill JK, Baker D, Davison AN, Maggon KK, Jaffee BD, Turk JL. Therapy of chronic relapsing experimental allergic encephalomyelitis and the role of the blood- brain barrier: elucidation by the action of Brequinar sodium. Journal of Neuroimmunology 1992;38:53-62.
43. Olechowski CJ, Truong JJ, Kerr BJ. Neuropathic pain behaviours in a chronic- relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain 2009;141:156-64.
44. Polman CH, Killestein J. Statins for the treatment of multiple sclerosis: cautious hope. Lancet 2004;363:1570. (Pubitemid 38625657)
45. Pryce G, Ahmed Z, Hankey DJ, Jackson SJ, Croxford JL, Pocock JM, Ledent C, Petzold A, Thompson AJ, Giovannoni G, Cuzner ML, Baker D. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 2003;126:2191-202. (Pubitemid 37432364)
46. Pryce G, Baker D. Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors. Br J Pharmacol 2007;150:519-25. (Pubitemid 46280648)
47. Pryce G, O'Neill JK, Croxford JL, Amor S, Hankey DJ, East E, Giovannoni G, Baker D. Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis. Journal of Neuroimmunology 2005;165:41-52. (Pubitemid 40984622)
48. Raine CS, Barnett LB, Brown A, Behar T, McFarlin DE. Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Laboratory Investigations 1980;43:150-7. (Pubitemid 10043144)
49. Rice GP, Filippi M, Comi G. Cladribine and progressive MS: clinical and MR1 outcomes of a multicenter controlled trial. Cladribine MR1 Study Group. Neurology 2000;54:1145-55. (Pubitemid 30151860)
50. Smith PA, Morris-Downes M, Heijmans N, Pryce G, Arter E, O'Neill JK, t Hart B, Baker D, Amor S. Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice. Journal of Neuroimmunology 2005;164:76-84. (Pubitemid 40826764)
51. Vesterinen HM, Sena ES, ffrench-Constant C, Williams A, Chandran S, Macleod MR. Improving the translational hit of experimental treatments in multiple sclerosis. Multiple Sclerosis 2010;16:1044-55.
52. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992;356:63-6.